Author:
Wu Depei,Du Xin,Jin Jie,Xiao Zhijian,Shen Zhixiang,Shao Zonghong,Li Xiao,Huang Xiaojun,Liu Ting,Yu Li,Li Jianyong,Chen Baoan,He Guangsheng,Cai Zhen,Liang Hongchuang,Li Jigang,Ruan Changgeng
Funder
Xian-Janssen Pharmaceutical Ltd. China
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference41 articles.
1. Liew E, Owen C. Familial myelodysplastic syndromes: a review of the literature. Haematologica. 2011;96:1536–42.
2. Seiter K. Myelodysplasia: new approaches. Curr Treat Options Oncol. 2013;14:156–69.
3. Cheson BD, Bennett JM, Kantarjian H, et al. Report of an international working group to standardize response criteria for myelodysplastic syndromes. Blood. 2000;96:3671–4.
4. Garcia-Manero G. Myelodysplastic syndromes: 2012 update on diagnosis, risk-stratification, and management. Am J Hematol. 2012;87:692–701.
5. Seer.cancer.gov [Internet] Survellience Research Program, NCI [updated September 10, 2014]. http://seer.cancer.gov/csr/1975_2011 . Accessed 27 Sept 2014.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献